spacer
 
|

Click below to register.

Wednesday, October 4th, 2017
San Diego, CA

Marriott Marquis San Diego Marina
333 W Harbor Drive
San Diego, California
Room: Ballroom F and G


11:00 AM – 11:30 AM: Registration and Lunch
11:30 PM – 1:00 PM: Interactive CME Activity

OVERVIEW
An estimated 2 million patients are diagnosed with antibiotic-resistant infections annually in the United States, many of which are caused by gram-negative (GN) bacteria. In hospitals and healthcare settings nationwide, healthcare providers (HCPs) continue to face vexing challenges in the clinical management and successful treatment of patients with complicated or multi-drug resistant GN bacterial infections. While nearly all HCPs recognize the gravity associated with antibiotic resistance, inappropriate prescribing patterns persist in clinical practice. There are emerging options that may be more effective in managing patients with harder-to-treat GN pathogens. However, in the absence of judicious use of novel antibiotics, acquired resistance to these new agents is inevitable. Through case-based presentations and expert discussion, this live interactive symposium will present strategies for the appropriate use of antibiotics, as well as innovative options for physicians to manage and treat their patients with multi-drug resistant GN infections.

GOAL
The goal of this activity is to provide clinicians with appropriate antibiotic prescribing strategies as well as education about novel and emerging options for treating and managing their patients with complicated and multi-drug resistant GN infections.

TARGET AUDIENCE
This activity has been designed to meet the educational needs of infectious disease, critical care, and hospital medicine providers who will be in attendance at the ID Week Conference.

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:
  • DISCUSS the prevalence of toxicities and administrative challenges with currently available IV formulations of treatments for serious infections.
  • DESCRIBE challenges with the treatment of complicated and multi-drug resistant gram negative infections.
  • EVALUATE emerging antibiotic treatment options for multi-drug resistant gram negative infections.
  • UTILIZE appropriate antibiotic prescribing practice strategies to optimize treatment and prevent resistance.

AGENDA
11:00 AM – 11:30 AM Registration and Lunch
11:30 AM – 11:45 AM Introduction: Complicated and Multi-drug Resistant Gram-negative Infections
Andrew Shorr, MD, MPH
11:45 AM – 12:15 PM Antibiotic Stewardship
Brad Spellberg, MD
12:15 PM – 12:45 PM Emerging Options and Determining Optimal Treatment Selection
Keith A. Rodvold, PharmD, FCCP, FIDSA
12:45 PM – 1:00 PM Conclusions and Questions and Answer Session
Faculty Panel

PARTICIPATING FACULTY
Andrew Shorr, MD, MPH (Course Director)
Director of Pulmonary and Critical Care Medicine
Director, Medical Intensive Care Unit
MedStar Washington Hospital Center
Professor of Medicine
Georgetown University School of Medicine
Washington, DC

Keith A. Rodvold, PharmD, FCCP, FIDSA
Professor of Pharmacy Practice and Medicine
Colleges of Pharmacy and Medicine
University of Illinois at Chicago
Chicago, Illinois

Brad Spellberg, MD
Chief Medical Officer
Los Angeles County, University of Southern California Medical Center
Professor of Clinical Medicine
Associate Dean for Clinical Affairs
Keck School of Medicine
Los Angeles, California

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

PHYSICIAN CONTINUING MEDICAL EDUCATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ASiM. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activit.

AMERICANS WITH DISABILITIES ACT (ADA)
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Cathy Zehr prior to the live event at 908-253-9001 ext. 15 or czehr@asimcme.com for more information.

FEE INFORMATION
There is no fee for this educational activity.

Submit a case to review at meeting:


<img src="http://www.jhasio1.com/asim/pictures/proceed_pretestASIM.png" alt="procced to pretest" border="0" />


spacer  
  spacer
Advanced Studies in Medicine © 2014 Contact Us
spacer  
spacer